Sandymount Therapeutics Ltd
- Company number
- 13514842
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 16 Jul 2021
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- Amgen UK Holdings Limited (3 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WALKER, Christopher Paul | Director | 30 Dec 2025 | 3 Jul 2026 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dark Blue Therapeutics Ltd | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
16 Jul 2021 |
Accounts
| Year ended | Net assets | Employees |
|---|---|---|
| 30 Jun 2025 Dormant | £1 | 0 |
| 30 Jun 2024 Dormant | £1 | 0 |
| 30 Jun 2023 | £1 | 1 |
| 30 Jun 2022 | £1 | 1 |
Connections
Owned by
Sandymount Therapeutics Ltd → Dark Blue Therapeutics Ltd → Amgen UK Holdings Limited
Companies at the same address
- Kleidox Therapeutics Ltd (12998606)